Australia Patent: Application for 'Tryptamine-based SHIP inhibitors for the treatment of cancer' Lapses

Press/Media: Expert Comment

PeriodJul 29 2022

Media coverage

1

Media coverage

  • TitleAustralia Patent: Application for 'Tryptamine-based SHIP inhibitors for the treatment of cancer' Lapses
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date7/29/22
    PersonsJohn D Chisholm